Neurochemical alterations of the entorhinal cortex in amnestic mild cognitive impairment (aMCI): A three-year follow-up study

Archives of Gerontology and Geriatrics

Volumn 54, Issue 1, 2012, Pages 192-196

  Seo, Sang Won ^a   Lee, Jung Hee ^a   Jang, Sung Man ^a   Kim, Sung Tae ^a   Chin, Juhee ^a   Kim, Geon Ha ^a   Kim, Jong Hun ^b   Roh, Jee Hoon ^c   Kim, Min Jeong ^d   Kim, Sook Hui ^e   Na, Duk L ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Seoul National University Boramae Hospital   (South Korea)

^e Konkuk University Hospital   (South Korea)

Author keywords

Alzheimer disease; Amnestic MCI; Conversion; Entorhinal cortex; Magnetic resonance spectroscopy

Indexed keywords

CREATININE; N ACETYLASPARTIC ACID; NEUROTRANSMITTER;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENTORHINAL CORTEX; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MALE; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; PREDICTION; PRIORITY JOURNAL; WHITE MATTER;

AGED; AMNESIA; ASPARTIC ACID; CREATININE; ENTORHINAL CORTEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 80054959328     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2011.04.002     Document Type: Article

References (20)

1. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berl.) 1991, 82:239-259.
2. Bruscoli M., Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int. Psychogeriatr. 2004, 16:129-140.
3. Catani M., Cherubini A., Howard R., Tarducci R., Pelliccioli G.P., Piccirilli M., Gobbi G., Senin U., Mecocci P. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 2001, 12:2315-2317.
4. Chételat G., Desgranges B., De La Sayette V., Viader F., Eustache F., Baron J.C. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002, 13:1939-1943.
5. Chételat G., Desgranges B., De la Sayette V., Viader F., Eustache F., Baron J.C. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology 2003, 60:1374-1377.
6. Huang W., Alexander G.E., Chang L., Shetty H.U., Krasuski J.S., Rapoport S.I., Schapiro M.B. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)HMRS study. Neurology 2001, 57:626-632.
7. Kang Y., Na D.L. Seoul Neuropsychological Screening Battery 2003, Human Brain Research & Consulting Co, Incheon, Seoul.
8. 1H MRS study. Neurology 2000, 55:210-217.
9. 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2007, 28:1330-1339.
10. Karas G.B., Scheltens P., Rombouts S.A., Visser P.J., Van Schijndel R.A., Fox N.C., Barkhof F. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004, 23:708-716.
11. Kim H., Na D.L. Normative data on the Korean version of the Boston Naming Test. J. Clin. Exp. Neuropsychol. 1999, 21:127-133.
12. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
13. Markesbery W.R., Schmitt F.A., Kryscio R.J., Davis D.G., Smith C.D., Wekstein D.R. Neuropathologic substrate of mild cognitive impairment. Arch. Neurol. 2006, 63:38-46.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
15. Metastasio A., Rinaldi P., Tarducci R., Mariani E., Feliziani F.T., Cherubini A., Pelliccioli G.P., Gobbi G., Senin U., Mecocci P. Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy. Neurobiol. Aging 2006, 27:926-932.
16. Nestor P.J., Fryer T.D., Smielewski P., Hodges J.R. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann. Neurol. 2003, 54:343-351.
17. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256:183-194.
18. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
19. Seo S.W., Im K., Lee J.M., Kim Y.H., Kim S.T., Kim S.Y., Yang D.W., Kim S.I., Cho Y.S., Na D.L. Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007, 36:289-297.
20. Visser P.J., Verhey F.R., Hofman P.A., Scheltens P., Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2002, 72:491-497.